The presence in carcinomas of large numbers of myofibroblasts (MFs) originally suggested the concept of cancer as a non-healing wound, and experiments have now implicated these cells as contributing to cancer growth, invasion and metastasis. Recently our labs (Tycko collaborating with Wang) showed that cancerassociated myofibroblasts (CAFs) in human gastric carcinomas (GCAs) and in a mouse model of GCA have globally reduced DNA methylation and focal gains of promoter methylation, compared to normal MFs in the stomach. We now have substantial unpublished data indicating that these findings of altered DNA methylation in CAFs extend to pancreatic carcinoma (PnCA), and that the demethylating drug decitabine (5aza-dC) has strong anti-tumor activity in a mouse model of PnCA, mediated in part through its effects on the tumor-supporting activity of CAFs and in part via its direct effects on the malignant epithelial cells. To build on these findings we have 4 current objectives - all centered on DNA methylation as a therapeutic target in both the supportive CAFs and malignant epithelial cells of stroma-rich gastrointestinal cancers. First, we will carry out several types of molecular assays to ask whether CAFs accumulate global and genespecific alterations in DNA methylation in pancreatic and hepatocellular carcinomas. Second, we will use mixing/allografting experiments to ask whether the demethylating drug decitabine inhibits the tumorsupporting function of CAFs, and we will profile gene expression and characterize mesenchymal stem cell markers in response to this drug to gain insights to its mechanisms of action against CAFs. Third, we will use in vivo mouse models of PnCA to test whether decitabine, alone and in combination with other agents, can prevent tumor progression and lead to regression of established PnCA tumors. This objective is linked to a Phase 1 clinical trial of decitabine in humans with PnCA, for which we will carry out the laboratory-based pharmacodynamic studies. Our fourth and last objective is to use a genetic strategy in mice to test whether deletion of the maintenance methyltransferase gene Dnmtl, specifically in MFs, can slow or prevent liver fibrosis and cancer in a chemical carcinogenesis model of hepatocellular carcinoma.

Public Health Relevance

Our study will address the role of myofibroblasts in pancreatic and hepatocellular carcinomas, with a particular focus on DNA methylation in these stromal cells as a target for anti-cancer therapy. Since these difficult to treat cancer types contain large numbers of tumor-promoting myofibroblasts, understanding how such cells promote cancer and how they can be inhibited with specific drugs is highly clinically relevant.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-3 (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Caviglia, Jorge Matias; Yan, Jun; Jang, Myoung-Kuk et al. (2017) MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology :
Pradère, Jean-Philippe; Hernandez, Céline; Koppe, Christiane et al. (2016) Negative regulation of NF-?B p65 activity by serine 536 phosphorylation. Sci Signal 9:ra85
Boggs, Kristin; Venkatesan, Nandakumar; Mederacke, Ingmar et al. (2016) Contribution of Underlying Connective Tissue Cells to Taste Buds in Mouse Tongue and Soft Palate. PLoS One 11:e0146475
Mu, Xueru; Pradere, Jean-Philippe; Affò, Silvia et al. (2016) Epithelial Transforming Growth Factor-? Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma. Gastroenterology 150:720-33
Manuel, Edwin R; Chen, Jeremy; D'Apuzzo, Massimo et al. (2015) Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. Cancer Immunol Res 3:1096-107
Mu, Xueru; Español-Suñer, Regina; Mederacke, Ingmar et al. (2015) Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest 125:3891-903
Duann, Pu; Li, Haichang; Lin, Peihui et al. (2015) MG53-mediated cell membrane repair protects against acute kidney injury. Sci Transl Med 7:279ra36
Caviglia, Jorge Matias; Schwabe, Robert F (2015) Mouse models of liver cancer. Methods Mol Biol 1267:165-83
Luedde, Tom; Kaplowitz, Neil; Schwabe, Robert F (2014) Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147:765-783.e4
Huebener, Peter; Gwak, Geum-Youn; Pradere, Jean-Philippe et al. (2014) High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab 19:539-47

Showing the most recent 10 out of 21 publications